investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Pathstone Family Office 13F Filing Shows Decrease in Overall Holdings in Q4 2022, With Increases in Coca-Cola Co. and UnitedHealth Group, and Decreases in Apple Inc. and Microsoft Corporation.

Ava Hoppe | 19 April, 2023

Pathstone Family Office, LLC is a New York-based multi-family office that primarily serves ultra-high-net-worth families and institutions. As of Q4 2022, Pathstone has reported its 13F holdings, indicating a comparison between its Q3 2022 and Q4 2022 holdings.

The 13F filing reveals that Pathstone has decreased its overall holdings in Q4 2022, with a decrease of approximately 1.1 million shares compared to its Q3 2022 holdings. The total value of Pathstone's holdings decreased from $3.7 billion to $3.3 billion, representing a 10.8% decrease.

Looking at the individual holdings, Pathstone reduced its position in Microsoft Corporation (MSFT) by 23.7%. During Q3 2022, Pathstone held 996,055 shares of MSFT, with a market value of $291.7 million. By Q4 2022, Pathstone had decreased its MSFT holdings to 995,143 shares, with a market value of $222.6 million.

On the other hand, Pathstone increased its Coca-Cola Co. (KO) holdings by 15.4%. In Q3 2022, Pathstone held 2,917,602 shares of KO, with a market value of $163.5 million. By Q4 2022, Pathstone had increased its KO holdings to 2,932,115 shares, with a market value of $188.8 million.

Pathstone's holdings in the Vanguard Index Funds (VV), which offers broad exposure to the U.S. stock market, increased by 6.4% over the reporting period. In Q3 2022, Pathstone held 1,007,732 shares of VV, with a market value of $164.8 million. By Q4 2022, Pathstone had increased its VV holdings to 1,012,102 shares, with a market value of $175.3 million.

Another significant increase in holdings was in the Vanguard Tax-Managed Funds (VEA), increasing by 16.2%. In Q3 2022, Pathstone held 3,774,959 shares of VEA, with a market value of $137.2 million. By Q4 2022, Pathstone had increased its VEA holdings to 3,972,366 shares, with a market value of $159.5 million.

Pathstone also recorded a decrease in holdings in the SPDR S&P 500 ETF Trust (SPY), with a decline of 4.6%. In Q3 2022, Pathstone held 454,928 shares of SPY, with a market value of $164.4 million. By Q4 2022, Pathstone had decreased its SPY holdings to 487,691 shares, with a market value of $156.9 million.

Apple Inc. (AAPL) also saw a decrease in Pathstone's holdings, decreasing by 31.7%. In Q3 2022, Pathstone held 1,421,781 shares of AAPL, with a market value of $202.9 million. By Q4 2022, Pathstone had decreased its AAPL holdings to 1,382,922 shares, with a market value of $138.6 million.

UnitedHealth Group Incorporated (UNH) saw the biggest increase in its holdings by Pathstone, with an increase of 332.8%. In Q3 2022, Pathstone held 52,110 shares of UNH, with a market value of $26.8 million. By Q4 2022, Pathstone had increased its UNH holdings to 55,242 shares, with a market value of $116.1 million.

The 13F filing also shows that Pathstone initiated new positions in some companies and exited positions in others. For instance, Pathstone initiated a new position in Zimvie Inc. (ZIMV) with 1,234 shares, worth $36,341, and also initiated a position in the Dimensional ETF Trust (DFIC) with 2,388,397 shares, valued at $53.4 million. Pathstone exited its positions in SPDR Ser Tr (TFI), which were worth $33.6 million, and also in shares of Dimensional ETF Trust (DFAT), worth $16.1 million.

In conclusion, Pathstone Family Office, LLC's Q4 2022 13F filing reveals that the firm has decreased its overall holdings compared to Q3 2022. The holding patterns of individual companies indicate that there have been both increases and decreases in holdings, mainly driven by market fluctuations, company performance, and investment strategy. It's worth noting that Pathstone's holdings represent a tiny fraction of its overall management, which mainly focuses on bespoke solutions for wealthy clients.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.